Solutions by Therapeutic Area
Anticancer
We offer a wide range of anticancer efficacy evaluation services. Through in vivo efficacy tests (Xenograft, Allograft, Humanized Mouse Models), we systematically analyze the efficacy of anticancer drugs, and through cytotoxicity assays, we validate the cellular-level mechanisms of these drugs. Our precise research delivers reliable and high-quality data.
If you require data for successful anticancer drug development and entry into the global market, leave it to us. We are committed to supporting your innovative success with optimal solutions.
Anticancer FAQs
Is IVIS analysis available?
Yes, IVIS (In Vivo Imaging System) enables real-time visualization and quantitative analysis of tumor growth inhibition effects. This non-invasive method delivers accurate and reliable data.
Are BSL-2 (Biosafety Level 2) experiments available?
Yes, our BSL-2 certified facilities can safely conduct experiments involving pathogenic viruses or specific biological agents.
How long does anticancer efficacy evaluation take?
On average, it takes 4 to 12 weeks, depending on experimental design and research scope. A detailed schedule is provided during the initial consultation.
Is spatial transcriptomics analysis available?
Yes, spatial transcriptomics visualizes gene expression within tissues, providing deeper insights into drug mechanisms. This allows precise analysis of drug responsiveness and changes in the tumor microenvironment.